Michael von Bergwelt-Baildon

7PUBLICATIONS
63CO-AUTHORS
HaematologyRespiratory diseasesTumour immunologyPacific Peoples cultural determinants of healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2026
The HLH-Risk-Calculator is a machine learning-based tool to predict course & mortality of secondary hemophagocytic lymphohistiocytosis.

|May 27, 2025
Clinical features, course, and risk factors of infection-associated secondary hemophagocytic lymphohistiocytosis.

Michael Ruzicka, Thomas Wimmer, Hans-Joachim Stemmler

|Dec 11, 2024
Tertiary Lymphoid Structures in Pancreatic Cancer are Structurally Homologous, Share Gene Expression Patterns and B-cell Clones with Secondary Lymphoid Organs, but Show Increased T-cell Activation.

Jonas Lehmann, Martin Thelen, Christoph Kreer

|Nov 13, 2023
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications.

Michael Ruzicka, Gerardo Jesus Ibarra Fonseca, Simone Sachenbacher

|Apr 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy.

Kai Rejeski, David M Cordas Dos Santos, Nathan H Parker

|Oct 04, 2022
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.

Michael Ruzicka, Sonja Wurm, Lars Lindner

Pageof 2

Frequent Collaborators

5 joint publications

Michael von Bergwelt-Baildon

4 joint publications

Michael Ruzicka

4 joint publications

Joachim H Stemmler

4 joint publications

Karsten Spiekermann